"Last ""year,"" the pharmaceutical industry had sales in excess of $300 billion. Both a diagnosis and a recommended course of ""treatment,"" this book reveals how market ""considerations,"" not medical ""need,"" determine the research agenda. A small number of corporations now dominate global ""healthcare,"" spending more on marketing than research and development. Law paints a future where the public and the medical profession once again have a voice in the kind of healthcare we want - and the healthcare we pay for."